Evidence map›Paper›PMID 36350143›Full record

ArticleMicrobiology spectrum2022

Modular Inducible Multigene Expression System for Filamentous Fungi.

Clara Baldin, Alexander Kühbacher, Petra Merschak, Johannes Wagener, Fabio Gsaller

Abstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Improving recombinant protein secretion inMetabolic engineering communications · 2025
    Article
  6. Article
  7. Article
  8. Shining a light on the impact of antifungals onAntimicrobial agents and chemotherapy · 2024
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Clara BaldinInstitute of Molecular Biology, Biocenter Innsbruck, Medical University of Innsbruck, Innsbruck, Austria.
Alexander KühbacherInstitute of Molecular Biology, Biocenter Innsbruck, Medical University of Innsbruck, Innsbruck, Austria.
Petra MerschakInstitute of Molecular Biology, Biocenter Innsbruck, Medical University of Innsbruck, Innsbruck, Austria.
Johannes WagenerDepartment of Clinical Microbiology, School of Medicine, Trinity College Dublin, The University of Dublin, Dublin, Ireland.ORCID 0000-0002-5952-9422
Fabio GsallerInstitute of Molecular Biology, Biocenter Innsbruck, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-9257-8648

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inducible promoters are indispensable elements when considering the possibility to modulate gene expression on demand. Desirable traits of conditional expression systems include their capacity for tight downregulation, high overexpression, and in some instances for fine-tuning, to achieve a desired product's stoichiometry. Although the number of inducible systems is slowly increasing, suitable promoters comprising these features are rare. To date, the concomitant use of multiple regulatable promoter platforms for controlled multigene expression has been poorly explored. This work provides pioneer work in the human pathogenic fungus Aspergillus fumigatus, wherein we investigated different inducible systems, elucidated three candidate promoters, and proved for the first time that up to three systems can be used simultaneously without interfering with each other. Proof of concept was obtained by conditionally expressing three antifungal drug targets within the ergosterol biosynthetic pathway under the control of the xylose-inducible

Indexed as

FungiTetracyclineAnti-Bacterial AgentsAntifungal AgentsHumansPromoter Regions, GeneticAnti-Bacterial AgentsAntifungal AgentsTetracyclineantifungal resistanceAspergillus fumigatusergosterol biosynthesisfilamentous fungiinducible promotersmultigene expression

Identifiers

PMID36350143
PMCPMC9769661

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.